opc 3911 has been researched along with propranolol in 1 studies
Studies (opc 3911) | Trials (opc 3911) | Recent Studies (post-2010) (opc 3911) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
---|---|---|---|---|---|
16 | 0 | 0 | 33,310 | 3,406 | 3,218 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belfrage, P; Degerman, E; Ekholm, D; Eriksson, H; Manganiello, VC; Ridderstråle, M; Smith, CJ; Tornqvist, H | 1 |
1 other study(ies) available for opc 3911 and propranolol
Article | Year |
---|---|
Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipocytes; Animals; Cyclic GMP; Insulin; Lipolysis; Male; Phosphodiesterase Inhibitors; Propranolol; Quinolones; Rats; Rats, Sprague-Dawley; Sterol Esterase | 1995 |